Noninvasive quantitation of drug concentration in prostate and seminal vesicles: Improvement and validation with desipramine and aspirin

Journal of Clinical Pharmacology

Volumn 48, Issue 2, 2008, Pages 176-183

  Cao, Ying Jun ^a   Caffo, Brian ^b   Choi, Leena ^c   Radebaugh, Christine L ^a   Fuchs, Edward J ^a   Hendrix, Craig W ^a,d  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^c VANDERBILT UNIVERSITY   (United States)

^d NONE   (United States)

Author keywords

Male genital tract; Modeling; Pharmacokinetics; Quantitative clinical pharmacology; Semen

Indexed keywords

ACETYLSALICYLIC ACID; DESIPRAMINE; PROSTATE SPECIFIC ANTIGEN;

ADULT; ARTICLE; CONTROLLED STUDY; DRUG ACCUMULATION; DRUG BLOOD LEVEL; HUMAN; HUMAN EXPERIMENT; MALE; MALE GENITAL SYSTEM; NON INVASIVE PROCEDURE; NORMAL HUMAN; PROSTATE; QUANTITATIVE ANALYSIS; SEMINAL VESICLE; SPERM; VALIDATION STUDY;

ADMINISTRATION, ORAL; ADOLESCENT; ADULT; ALGORITHMS; ASPIRIN; BAYES THEOREM; BIOMARKERS, PHARMACOLOGICAL; CHROMATOGRAPHY; DESIPRAMINE; EJACULATION; FRUCTOSE; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; OUTPATIENTS; PROSTATE; PROSTATE-SPECIFIC ANTIGEN; REPRODUCIBILITY OF RESULTS; SALICYLATES; SEMEN; SEMINAL VESICLES; SEXUAL DYSFUNCTION, PHYSIOLOGICAL; TANDEM MASS SPECTROMETRY;

EID: 38349090454     PISSN: 00912700     EISSN: 15524604     Source Type: Journal    
DOI: 10.1177/0091270007310547     Document Type: Article

References (26)

1. Collins MM, Stafford RS, O'Leary MP, Barry MJ How common is prostatitis? A national survey of physician visits. J Urol. 1998 ; 159 (4). 1224-1228.
2. Jemal A., Murray T., Ward E., et al. Cancer statistics, 2005. CA Cancer J Clin. 2005 ; 55 (1). 10-30.
3. Thorpe A., Neal D. Benign prostatic hyperplasia. Lancet. 2003 ; 361 (9366). 1359-1367.
4. Choe W., Kan Ryu J., Kim WH, Chung MH, Suh JK Imaging seminal vesiculitis with Tc-99m ciprofloxacin. Clin Nucl Med. 2003 ; 28 (6). 501-502.
5. Joly-Guillou ML, Lasry S. Practical recommendations for the drug treatment of bacterial infections of the male genital tract, including urethritis, epididymitis, and prostatitis. Drugs. 1999 ; 57 (5). 743-750.
6. Krieger JN Epididymitis, orchitis, and related conditions. Sex Transm Dis. 1984 ; 11 (3). 173-181.
7. Centers for Disease Control and Prevention. http://www.cdc.gov/hiv/ topics/surveillance/resources/slides/general/slides/general.pdf. Accessed on January 9, 2007.
8. Zhu T., Wang N., Carr A., et al. Genetic characterization of human immunodeficiency virus type 1 in blood and genital secretions: evidence for viral compartmentalization and selection during sexual transmission. J Virol. 1996 ; 70 (5). 3098-3107.
9. Xu C., Politch JA, Tucker L., Mayer KH, Seage GR 3rd, Anderson DJ. Factors associated with increased levels of human immunodeficiency virus type 1 DNA in semen. J Infect Dis. 1997 ; 176 (4). 941-947.
10. Anderson DJ, O'Brien TR, Politch JA, et al. Effects of disease stage and zidovudine therapy on the detection of human immunodeficiency virus type 1 in semen. JAMA. 1992 ; 267 (20). 2769-2774.
11. Taylor S., Pereira AS Antiretroviral drug concentrations in semen of HIV-1-infected men. Sex Transm Infect. 2001 ; 77 (1). 4-11.
12. Chan DJ Pathophysiology of HIV-1 in semen: current evidence for compartmentalization and penetration by antiretroviral drugs. Curr HIV Res. 2005 ; 3 (3). 207-222.
13. Kepler TB, Perelson AS Drug concentration heterogeneity facilitates the evolution of drug resistance. Proc Natl Acad Sci USA. 1998 ; 95 (20). 11514-11519.
14. Ndovi TT, Choi L., Caffo B., et al. Quantitative assessment of seminal vesicle and prostate drug concentrations by use of a noninvasive method. Clin Pharmacol Ther. 2006 ; 80 (2). 146-158.
15. Ndovi TT, Parsons T., Choi L., Caffo B., Rohde C., Hendrix CW A new method to estimate quantitatively seminal vesicle and prostate gland contributions to ejaculate. Br J Clin Pharmacol. 2006 ; 63 (4). 404-420.
16. Lundquist F. Aspects of the biochemistry of human semen. Acta Physiologica Scandinavica. 1949 ; 19: 1-95.
17. Choi L., Caffo BS, Rohde C., Ndovi TT, Hendrix CW A mechanistic latent variable model for estimating drug concentrations in the male genital tract: a case study in drug kinetics. Stat Med. 2007 Oct 22; [Epub ahead of print].
18. Weiner D., Garteiz D., Cawein M., Dusebout T., Wright G., Okerholm R. Pharmacokinetic linearity of desipramine hydrochloride. J Pharm Sci. 1981 ; 70 (9). 1079-1080.
19. Cooke RG, Warsh JJ, Stancer HC, Reed KL, Persad E. The nonlinear kinetics of desipramine and 2-hydroxydesipramine in plasma. Clin Pharmacol Ther. 1984 ; 36 (3). 343-349.
20. Yeragani VK Anorgasmia associated with desipramine. Can J Psychiatry. 1988 ; 33 (1). 76.
21. Rosenbaum JF, Pollack MH Anhedonic ejaculation with desipramine. Int J Psychiatry Med. 1988 ; 18 (1). 85-88.
22. Balon R., Yeragani VK, Pohl R., Ramesh C. Sexual dysfunction during antidepressant treatment. J Clin Psychiatry. 1993 ; 54 (6). 209-212.
23. Hsu JH, Shen WW Male sexual side effects associated with antidepressants: a descriptive clinical study of 32 patients. Int J Psychiatry Med. 1995 ; 25 (2). 191-201.
24. Rothschild AJ Sexual side effects of antidepressants. J Clin Psychiatry. 2000 ; 61 (Suppl 11). 28-36.
25. Fair WR, Cordonnier JJ The pH of prostatic fluid: a reappraisal and therapeutic implications. J Urol. 1978 ; 120 (6). 695-698.
26. Kershaw RA, Mays DC, Bianchine JR, Gerber N. Disposition of aspirin and its metabolites in the semen of man. J Clin Pharmacol. 1987 ; 27 (4). 304-309.